See more : RiverNorth Capital and Income Fund, Inc. (RSF) Income Statement Analysis – Financial Results
Complete financial analysis of Shalby Limited (SHALBY.BO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Shalby Limited, a leading company in the Medical – Care Facilities industry within the Healthcare sector.
- Avid Technology, Inc. (AVID) Income Statement Analysis – Financial Results
- Mobilicom Limited (MOBBW) Income Statement Analysis – Financial Results
- Marimaca Copper Corp. (CROJF) Income Statement Analysis – Financial Results
- Sambu Engineering & Construction Co., Ltd (001470.KS) Income Statement Analysis – Financial Results
- Tantalus Systems Holding Inc. (GRID.TO) Income Statement Analysis – Financial Results
Shalby Limited (SHALBY.BO)
About Shalby Limited
Shalby Limited operates multi-specialty hospitals primarily in India, North America, Japan, and Indonesia. The company offers arthroscopy, arthroplasty, cardiology, cardiothoracic and vascular surgery, cosmetic and aesthetic, dental cosmetic and implantology, emergency medicine, endocrinology, endoscopy and laparoscopy, ENT surgery, gastroentero surgery, gastroenterology, general medicine and surgery, hair transplant, liver transplant, dermatology, psychiatry, urology, anesthesia, and hip and knee joint replacement services. It also provides infectious disease, infertility and IVF, intensive and critical care, maxillofacial surgery, nephrology, neurosurgery, neurology, obesity surgery, obstetrics and gynecology, oncology, oncosurgery, ophthalmology and glaucoma, orthopedic and trauma, pediatric orthopedic, pathology and microbiology, pediatrics and neonatology, plastic surgery, pulmonology and chest, radiology and imaging, rheumatology, trauma, spine surgery, and urosurgery services, as well as organ donation. In addition, it offers outpatient services, as well as provides educational programs for paramedical students and other healthcare professionals; and homecare services, such as ICU at home, diagnostics, attendants, doctor visit, nursing care, physiotherapy, pharmacy, and medical equipment. The company was formerly known as Shalby Hospitals Limited and changed its name to Shalby Limited in February 2008. Shalby Limited was founded in 1994 and is headquartered in Ahmedabad, India.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 9.34B | 8.05B | 6.99B | 4.31B | 4.87B | 4.62B | 3.78B | 3.24B | 2.90B | 2.75B | 2.59B | 2.25B |
Cost of Revenue | 6.83B | 4.35B | 3.94B | 2.50B | 2.95B | 2.83B | 2.22B | 1.88B | 1.83B | 1.72B | 1.60B | 1.45B |
Gross Profit | 2.50B | 3.70B | 3.05B | 1.81B | 1.92B | 1.79B | 1.56B | 1.36B | 1.08B | 1.04B | 989.29M | 800.46M |
Gross Profit Ratio | 26.83% | 45.94% | 43.58% | 42.07% | 39.34% | 38.72% | 41.30% | 42.03% | 37.04% | 37.73% | 38.21% | 35.56% |
Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 42.26M | 50.89M | 61.03M | 14.65M | 11.87M | 13.15M | 18.52M | 14.43M | 10.68M | 6.50M | 6.51M | 7.63M |
Selling & Marketing | 223.34M | 200.99M | 86.04M | 37.92M | 85.63M | 68.91M | 71.27M | 45.71M | 41.20M | 17.72M | 25.35M | 18.18M |
SG&A | 265.60M | 251.88M | 147.07M | 52.57M | 97.50M | 82.06M | 89.79M | 60.14M | 51.88M | 24.22M | 31.86M | 25.81M |
Other Expenses | 0.00 | 52.05M | 14.65M | 7.86M | 8.57M | 8.03M | 44.88M | 3.89M | 4.29M | 2.20M | 2.15M | 3.27M |
Operating Expenses | 265.60M | 2.76B | 2.22B | 1.26B | 1.33B | 1.27B | 951.47M | 800.87M | 617.42M | 561.25M | 454.36M | 633.98M |
Cost & Expenses | 7.10B | 7.11B | 6.16B | 3.75B | 4.29B | 4.10B | 3.17B | 2.68B | 2.45B | 2.28B | 2.05B | 2.08B |
Interest Income | 34.26M | 79.30M | 72.15M | 52.30M | 51.52M | 65.39M | 30.26M | 17.72M | 8.52M | 4.43M | 6.11M | 13.46M |
Interest Expense | 160.33M | 79.72M | 58.85M | 29.11M | 52.19M | 70.50M | 113.93M | 93.56M | 65.15M | 37.80M | 20.09M | 3.01M |
Depreciation & Amortization | 522.44M | 480.88M | 428.70M | 367.95M | 360.20M | 331.73M | 228.56M | 167.02M | 113.33M | 212.37M | 110.13M | 271.85M |
EBITDA | 1.98B | 1.61B | 1.30B | 962.41M | 1.00B | 927.37M | 888.63M | 782.36M | 558.20M | 676.91M | 636.07M | 463.33M |
EBITDA Ratio | 21.21% | 19.42% | 18.95% | 22.48% | 20.13% | 19.61% | 23.49% | 23.49% | 18.51% | 24.90% | 25.54% | 20.53% |
Operating Income | 2.24B | 931.94M | 810.90M | 559.16M | 498.67M | 503.68M | 587.45M | 548.06M | 452.82M | 473.33M | 551.06M | 190.30M |
Operating Income Ratio | 23.98% | 11.58% | 11.60% | 12.98% | 10.24% | 10.90% | 15.54% | 16.93% | 15.59% | 17.19% | 21.29% | 8.45% |
Total Other Income/Expenses | -957.45M | 88.49M | -19.44M | -8.61M | -13.60M | -18.71M | -72.53M | -54.99M | -99.09M | -47.43M | -13.49M | -3.32M |
Income Before Tax | 1.28B | 1.02B | 791.46M | 550.55M | 567.27M | 503.88M | 537.29M | 504.97M | 359.24M | 430.34M | 521.44M | 186.98M |
Income Before Tax Ratio | 13.73% | 12.68% | 11.32% | 12.78% | 11.65% | 10.90% | 14.21% | 15.60% | 12.37% | 15.63% | 20.14% | 8.31% |
Income Tax Expense | 446.94M | 343.66M | 251.75M | 126.93M | 291.41M | 187.34M | 145.59M | 217.95M | -3.95M | 184.82M | 143.97M | 36.89M |
Net Income | 840.77M | 677.01M | 541.25M | 423.96M | 275.87M | 316.61M | 393.78M | 296.93M | 375.83M | 257.33M | 390.27M | 171.04M |
Net Income Ratio | 9.00% | 8.41% | 7.74% | 9.84% | 5.67% | 6.85% | 10.42% | 9.17% | 12.94% | 9.34% | 15.08% | 7.60% |
EPS | 7.78 | 6.30 | 5.01 | 3.93 | 2.55 | 2.93 | 4.17 | 3.40 | 3.48 | 2.38 | 3.61 | 1.58 |
EPS Diluted | 7.77 | 6.30 | 5.01 | 3.93 | 2.55 | 2.93 | 4.17 | 3.40 | 3.48 | 2.38 | 3.61 | 1.58 |
Weighted Avg Shares Out | 108.07M | 107.42M | 108.01M | 108.01M | 108.01M | 108.01M | 94.36M | 108.01M | 108.01M | 108.01M | 108.01M | 108.01M |
Weighted Avg Shares Out (Dil) | 108.21M | 107.42M | 108.01M | 108.01M | 108.01M | 108.01M | 94.36M | 108.01M | 108.01M | 108.01M | 108.01M | 108.01M |
Source: https://incomestatements.info
Category: Stock Reports